AMA CPT® Assistant - 2020 Issue 1 (January)
Uveal Melanoma (UM) Genetic Expression Profiling Code (January 2020)
January 2020 page 10 Uveal Melanoma (UM) Genetic Expression Profiling Code For the Current Procedural Terminology (CPT®) 2020 code set, the Proprietary Laboratory Analyses (PLA) subsection code 0081U was converted to a new Category I CPT code (81552) in the Multianalyte Assays with Algorithmic Analyses (MAAA) subsection to report mRNA analysis of 15 genes, including profiling and a calculated risk score for uveal melanoma (UM) metastasis. This article provides a brief overview of this procedure. Multianalyte Assays with Algorithmic Analyses 81552Oncology (uveal melanoma), mRNA, gene expression profiling by real-time RT-PCR of 15 genes (12 content and 3 housekeeping)...
Subscribe or sign in to view the full article.
Article Overview
This article explains a CPT 2020 change affecting uveal melanoma genetic expression profiling and summarizes the kind of laboratory analysis and reporting context involved. It is useful for coders, billing staff, ophthalmology practices, retina specialists, and laboratory professionals who need to understand the scope of the update and the general procedure being described. The article includes a high-level overview, a clinical example, and a procedural description tied to the revised coding structure.
Why This Topic Matters
Uveal melanoma testing is a specialized laboratory service used in ophthalmic oncology, and this article helps readers recognize the CPT code update and the clinical context in which the service is reported. It is relevant for staying aligned with current coding references for molecular pathology and algorithm-based laboratory analysis.
Article Sections
-
Multianalyte Assays with Algorithmic Analyses
Introduces the relevant CPT subsection and the laboratory testing context for uveal melanoma gene expression profiling. Summarizes the nature of the procedure at a broad level.
-
Clinical Example and Procedural Description
Provides a brief illustrative patient scenario and a procedural description associated with the testing workflow. The section frames the clinical setting in which the service may be reported.
What You Will Learn
- How the article frames the CPT 2020 update for uveal melanoma genetic expression profiling
- The general laboratory and clinical context for the procedure
- The type of content included in the article’s overview, example, and procedure summary
- How the update is positioned within the CPT Multianalyte Assays with Algorithmic Analyses subsection
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Ophthalmology practices
- Retina specialists
- Laboratory professionals
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com